title: [The mechanisms of nitric oxide production from exogenous and endogenous NO-donating compounds and its effect on deoxyribonucleotide and DNA synthesis].
abstract: The mechanisms of exogenous nitric oxide (NO) production through in vivo biotransformation of nitro-, nitroso- and amino-containing substances were discussed. In addition, the mechanisms of production and cellular sources of endogenous NO, appearing in the blood and tissues after the exposure to various DNA-damaging factors, have been considered. Considerable quantities of endogenous NO were detected in the body in the first hours after translation inhibition by cycloheximide or animal exposure to superlethal radiation doses, i.e., after the exposure to factors inducing destructive processes. The time and dose dependences of exogenous and endogenous NO production have been established. NO produced after a single or repeated administration of NO-donating compounds as well as endogenous NO proved to inhibit deoxyribonucleotide (dNTP) and DNA synthesis in animal tissues. Nonspecific compensatory responses to disturbed protein homeostasis included cyclic production of endogenous NO. The maximum levels of nitrosyl complexes were registered when the rate of protein synthesis decreased. The role of polyamines in the induction of macromolecule biosynthesis is discussed and NO production from these arginine-rich compounds is proposed. NO is released at the stage of polyamine inactivation. The inactivation mechanism includes the hydroxylation of aminogroups by NO synthase, the formation of nitroso intermediates, and their denitrosation with NO release.
authors.forename: M K
authors.initials: MK
authors.lastname: Pulatova
authors.forename: V L
authors.initials: VL
authors.lastname: Sharygin
authors.forename: G T
authors.initials: GT
authors.lastname: Rikhireva
authors.forename: Iu I
authors.initials: IuI
authors.lastname: Mitrokhin
authors.forename: I N
authors.initials: IN
authors.lastname: Todorov
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D015317:Biogenic Polyamines / Q000378:metabolism; D001711:Biotransformation; D003513:Cycloheximide / Q000494:pharmacology; D004247:DNA / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D003854:Deoxyribonucleotides / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D004578:Electron Spin Resonance Spectroscopy; D005720:Gamma Rays; D008297:Male; D008706:Methemoglobin / Q000032:analysis; D051379:Mice; D009569:Nitric Oxide / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology; D020030:Nitric Oxide Donors / Q000493:pharmacokinetics / Q000494:pharmacology*; D009928:Organ Specificity; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D051381:Rats; D012264:Ribonucleotide Reductases / Q000378:metabolism
chemical_list: D015317:Biogenic Polyamines; D003854:Deoxyribonucleotides; D020030:Nitric Oxide Donors; D011500:Protein Synthesis Inhibitors; D009569:Nitric Oxide; D004247:DNA; D008706:Methemoglobin; D003513:Cycloheximide; D012264:Ribonucleotide Reductases